Figure 6.The mechanism diagram illustrating that H19 participates in atherosclerotic vulnerable plaque formation and angiogenesis of mice with AS by inhibiting PKD1 expression via CTCF.
Figure 6 — Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice | Aging
